2-ethyl-2,5,5-trimethyl-3-oxazolidinoxyl has been researched along with Disease Models, Animal in 1 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Ghani, AA; Dashwood, RH; Eklof, B; Hasaniya, NW; McNamara, JJ; Premaratne, S; Razzuk, A; Tinsley, L; Zhang, WW | 1 |
1 other study(ies) available for 2-ethyl-2,5,5-trimethyl-3-oxazolidinoxyl and Disease Models, Animal
| Article | Year |
|---|---|
Amelioration of ischemia-reperfusion injury in an isolated rabbit lung model using OXANOH.
Topics: Animals; Antioxidants; Catalase; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Lung; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Oxazoles; Oxypurinol; Rabbits; Reactive Oxygen Species; Reperfusion Injury; Spin Labels; Superoxide Dismutase; Time Factors | 2011 |